Clinical Biochemistry — MCQs

Clinical Biochemistry Indian Medical PG Practice Questions and MCQs

Question 81: A 45-year-old male presents with a blood sample that yields a purple-brown color in Ehrlich's solution. What is the substance responsible for this color change?

A. Urobilinogen (Correct Answer)
B. Conjugated bilirubin
C. Unconjugated bilirubin
D. Hemosiderin

Explanation: ### Explanation **Correct Answer: A. Urobilinogen** The **Ehrlich’s Aldehyde Test** is a classic biochemical reaction used to detect urobilinogen in urine or blood. The reagent (Ehrlich’s reagent) consists of **p-dimethylaminobenzaldehyde** in concentrated hydrochloric acid. When this reagent reacts with urobilinogen, it forms a characteristic **cherry-red to purple-brown condensation product**. This is a high-yield clinical marker for hemolytic anemias and hepatocellular jaundice, where urobilinogen levels are significantly elevated. **Why the other options are incorrect:** * **B & C (Bilirubin):** Bilirubin (both conjugated and unconjugated) does not react with Ehrlich’s reagent. Conjugated bilirubin is typically detected using the **Fouchet’s test** (producing a green color) or the **Van den Bergh reaction** (producing a purple azobilirubin compound). * **D (Hemosiderin):** This is an iron-storage complex. It is detected using the **Prussian Blue (Perls') reaction**, which yields a deep blue color, not a purple-brown reaction with aldehyde reagents. **NEET-PG High-Yield Pearls:** * **Ehrlich’s Test:** Positive in hemolytic jaundice (increased production) and early hepatitis; **Negative/Absent** in obstructive jaundice (bile cannot reach the gut for conversion). * **Watson-Schwartz Test:** A modification of Ehrlich’s test used to differentiate between urobilinogen and **porphobilinogen (PBG)**. PBG is insoluble in chloroform, whereas urobilinogen is soluble. * **False Positives:** Certain drugs like sulfonamides and PAS (Para-aminosalicylic acid) can cause a false-positive Ehrlich’s reaction.

Question 82: In acute liver injury, what is the characteristic AST/ALT ratio?

A. An AST/ALT ratio < 1 occurs in most hepatocellular conditions. (Correct Answer)
B. An AST/ALT ratio > 2:1 is suggestive of alcoholic liver disease.
C. The synthesis of AST is inhibited by ethanol.
D. In alcoholic liver disease, the AST/ALT ratio is typically < 1.

Explanation: **Explanation:** In most forms of acute hepatocellular injury (such as viral hepatitis or toxin-induced damage), both AST and ALT are released from damaged hepatocytes. However, because **ALT is more specific to the liver** and has a longer half-life (~47 hours) compared to AST (~17 hours), ALT levels typically rise higher and stay elevated longer. Consequently, the **AST/ALT ratio is usually < 1** in most acute hepatocellular conditions. **Analysis of Options:** * **Option A (Correct):** As explained, ALT elevation predominates in acute viral or non-alcoholic inflammatory states, leading to a ratio < 1. * **Option B (Incorrect):** While an AST/ALT ratio > 2:1 is indeed highly suggestive of alcoholic liver disease, this option is considered a "distractor" in the context of the question's focus on general acute liver injury. In the hierarchy of biochemical principles, the predominance of ALT in non-alcoholic injury is the primary rule. * **Option C (Incorrect):** Ethanol does not inhibit AST synthesis. In fact, ethanol (specifically its metabolite acetaldehyde) causes mitochondrial damage, leading to increased release of mitochondrial AST. Conversely, ethanol **depletes Pyridoxal-5-Phosphate (Vitamin B6)**, which is a necessary cofactor for ALT synthesis, thereby lowering ALT levels. * **Option D (Incorrect):** In alcoholic liver disease, the ratio is typically **> 2:1** due to the reasons mentioned above (mitochondrial AST release and B6 deficiency affecting ALT). **High-Yield Clinical Pearls for NEET-PG:** * **AST/ALT > 2:1 + Elevated GGT:** Highly suggestive of Alcoholic Liver Disease. * **AST/ALT > 1 in Non-Alcoholic Fatty Liver Disease (NAFLD):** Often indicates progression to advanced fibrosis or cirrhosis. * **De Ritis Ratio:** The clinical term for the AST/ALT ratio. * **Highest absolute values:** AST and ALT levels > 1000 IU/L are typically seen in ischemic hepatitis (shock liver), paracetamol poisoning, or acute viral hepatitis (A or B).

Question 83: What is the normal serum alkaline phosphatase level?

A. 100-400 Bodansky units
B. 1000-4000 Bodansky units
C. 0.1-0.4 Bodansky units
D. 1-4 Bodansky units (Correct Answer)

Explanation: **Explanation:** Alkaline Phosphatase (ALP) is a hydrolase enzyme responsible for removing phosphate groups from molecules. In clinical biochemistry, its activity is measured to assess hepatobiliary and bone disorders. Historically, several units were used to express ALP levels before the standardization to International Units (IU/L). **1. Why Option D is Correct:** The **Bodansky unit** is defined as the amount of ALP required to liberate 1 mg of inorganic phosphorus from a substrate (sodium β-glycerophosphate) in one hour. The established normal reference range for adults in Bodansky units is **1–4 units/dL**. In children, this value is higher (up to 12 units/dL) due to active bone growth. **2. Analysis of Incorrect Options:** * **Option A & B (100–400 and 1000–4000):** These values are far too high for Bodansky units. However, 100–400 is closer to the numerical range seen when measuring ALP in **King-Armstrong (KA) units** (normal: 3–13 KA units) or **International Units** (normal: 30–120 IU/L), which can lead to confusion. * **Option C (0.1–0.4):** This range is too low and does not correspond to any standard clinical measurement for ALP. **3. Clinical Pearls for NEET-PG:** * **Isoenzymes:** ALP has several isoenzymes: **Alpha-1** (Liver), **Alpha-2** (Bone), **Pre-beta** (Placental), and **Gamma** (Intestinal). * **Heat Stability:** A high-yield mnemonic for heat stability is *"Regan is hot"* (Regan/Placental isoenzyme is the most heat-stable; Bone is the most heat-labile). * **Clinical Significance:** Markedly elevated ALP is a hallmark of **obstructive jaundice** (cholestasis) and **Paget’s disease of bone**. It is also physiological during the third trimester of pregnancy and during adolescent growth spurts.

Question 84: Which of the following enzymes is functional?

A. Alkaline phosphatase
B. Acid phosphatase
C. Lipoprotein lipase (Correct Answer)
D. Gamma glutamyl transpeptidase

Explanation: ### Explanation In clinical biochemistry, plasma enzymes are categorized into two groups: **Functional** and **Non-functional** plasma enzymes. **1. Why Lipoprotein Lipase is the Correct Answer:** Functional plasma enzymes are those that are actively secreted into the blood by specific organs (usually the liver) and perform their primary physiological function within the circulation. **Lipoprotein lipase (LPL)** is a classic example. It is synthesized in extrahepatic tissues and remains active in the vascular endothelium, where it hydrolyzes triglycerides found in chylomicrons and VLDL into free fatty acids and glycerol. Other examples include enzymes involved in blood coagulation (e.g., Thrombin) and fibrinolysis. **2. Why the Other Options are Incorrect:** * **Alkaline Phosphatase (ALP), Acid Phosphatase (ACP), and Gamma-glutamyl transpeptidase (GGT)** are **Non-functional plasma enzymes**. * These enzymes perform their primary metabolic functions **intracellularly** or within specific secretions (like bile or semen). * Under normal physiological conditions, they are present in the plasma in very low concentrations due to routine cell turnover. Their levels rise significantly only during tissue damage or disease (e.g., ALP in obstructive jaundice, ACP in prostate cancer), making them excellent diagnostic biomarkers. **Clinical Pearls for NEET-PG:** * **Functional Enzymes:** Substrate is always present in the blood. Examples: LPL, Pseudocholinesterase, Prothrombin. * **Non-functional Enzymes:** Substrate is absent in the blood; they are purely diagnostic markers. * **LPL Activator:** Apolipoprotein **C-II** is the essential cofactor for LPL activity. * **Heparin Connection:** Intravenous heparin releases LPL from the endothelial wall into the plasma, often referred to as "post-heparin lipolytic activity."

Question 85: Which of the following statements is true regarding glycosylated hemoglobin?

A. Increased in diabetic patients with sickle cell anemia.
B. It is a poor indicator of long-term diabetic status in patients with renal disease.
C. Contains hemoglobin with a sugar moiety. (Correct Answer)
D. Has a half-life of 45 days in adults.

Explanation: **Explanation:** **1. Why the correct answer is right:** Glycosylated hemoglobin (HbA1c) is formed by a **non-enzymatic, irreversible attachment** of glucose to the N-terminal valine residue of the beta-globin chain (glycation). Chemically, it consists of a hemoglobin molecule covalently bonded to a **sugar moiety**. This process is dependent on the ambient blood glucose concentration, making it a reliable marker for glycemic control. **2. Why the incorrect options are wrong:** * **Option A:** In patients with **Sickle Cell Anemia**, the lifespan of red blood cells (RBCs) is significantly reduced due to hemolysis. Since there is less time for glucose to bind to hemoglobin, HbA1c levels are **falsely decreased**, not increased. * **Option B:** While HbA1c can be affected by erythropoietin therapy or uremia in renal disease, it remains a standard tool. However, the statement is generally considered incorrect because HbA1c reflects the average glucose over 2-3 months; the "poor indicator" label is more accurately applied to conditions with high RBC turnover. * **Option D:** HbA1c does not have a half-life of 45 days. Instead, it reflects the **average lifespan of an RBC**, which is approximately **120 days**. It provides a retrospective index of blood glucose control over the preceding 8–12 weeks. **Clinical Pearls for NEET-PG:** * **Gold Standard:** HbA1c is the gold standard for monitoring long-term glycemic control. * **Target:** For most diabetic patients, the target HbA1c is **< 7%**. * **Fructosamine Test:** If HbA1c is unreliable (e.g., hemolytic anemia, pregnancy), the Fructosamine test (measuring glycated albumin) is used, reflecting control over the past **2–3 weeks**. * **False Lows:** Seen in Hemolytic anemia, acute blood loss, and Vitamin C/E supplementation. * **False Highs:** Seen in Iron deficiency anemia (due to increased RBC lifespan) and Splenectomy.

Question 86: Gastrin is a biochemical marker for which of the following tumors?

A. Medullary carcinoma of thyroid
B. Pancreatic neuroendocrine tumor (Correct Answer)
C. Pheochromocytoma
D. Gastrointestinal stromal tumor

Explanation: **Explanation:** **Gastrin** is a peptide hormone primarily produced by the G-cells of the gastric antrum and the duodenum. In a clinical oncology context, it serves as a specific biochemical marker for **Gastrinomas**. 1. **Why Option B is Correct:** Gastrinomas are a type of **Pancreatic Neuroendocrine Tumor (PanNET)**. While they can occur in the "Gastrinoma Triangle" (duodenum, pancreas, and porta hepatis), the pancreas is a classic site. These tumors hypersecrete gastrin, leading to **Zollinger-Ellison Syndrome (ZES)**, characterized by severe peptic ulcer disease and chronic diarrhea due to excessive gastric acid production. 2. **Why Other Options are Incorrect:** * **A. Medullary Carcinoma of Thyroid (MCT):** The primary biochemical marker is **Calcitonin**. Carcinoembryonic antigen (CEA) is also used for monitoring. * **C. Pheochromocytoma:** This tumor of the adrenal medulla secretes catecholamines. The diagnostic markers are urinary and plasma **Metanephrines** and Vanillylmandelic acid (VMA). * **D. Gastrointestinal Stromal Tumor (GIST):** These are mesenchymal tumors. The most important diagnostic marker is the expression of the **CD117 (c-KIT)** protein, identified via immunohistochemistry. **High-Yield Clinical Pearls for NEET-PG:** * **Gastrinoma Triangle:** Bound by the junction of the cystic and common bile duct, the junction of the 2nd and 3rd parts of the duodenum, and the neck of the pancreas. * **MEN-1 Association:** Approximately 25% of gastrinomas are associated with Multiple Endocrine Neoplasia Type 1 (3Ps: Parathyroid, Pancreas, Pituitary). * **Diagnostic Test:** The **Secretin Stimulation Test** is the provocative test of choice; a paradoxical rise in serum gastrin levels confirms a gastrinoma.

Question 87: A 40-year-old non-diabetic woman presents to the emergency department with hypoglycemia. The paramedics suspect an insulin overdose, while you suspect an insulinoma. Which laboratory result would confirm your suspicion of insulinoma?

A. Insulin level is significantly elevated compared to C-peptide level
B. Insulin level is significantly lower than C-peptide level
C. Insulin level is inappropriately high for the degree of hypoglycemia and is accompanied by a detectable C-peptide level (Correct Answer)
D. Insulin antibody level is equal to the insulin level

Explanation: ### Explanation The core concept in differentiating causes of hyperinsulinemic hypoglycemia is the source of the insulin: **Endogenous vs. Exogenous.** **1. Why the Correct Answer is Right:** Insulin is synthesized in pancreatic beta cells as **proinsulin**, which is cleaved into equimolar amounts of **mature insulin and C-peptide**. * In an **Insulinoma** (an endogenous insulin-secreting tumor), the pancreas secretes both insulin and C-peptide autonomously. * Therefore, during a hypoglycemic episode, the finding of high insulin levels accompanied by **elevated or detectable C-peptide levels** (typically ≥0.6 ng/mL) confirms that the insulin is being produced internally by the body. **2. Analysis of Incorrect Options:** * **Option A:** If insulin is significantly higher than C-peptide, it suggests **Exogenous Insulin Overdose** (factitious hypoglycemia). Commercial insulin preparations do not contain C-peptide; thus, insulin will be high, but C-peptide will be suppressed. * **Option B:** This is physiologically unlikely in hyperinsulinemic states. While C-peptide has a longer half-life than insulin, a massive discrepancy where insulin is "significantly lower" does not point to an insulinoma. * **Option C:** High insulin antibody levels suggest **Insulin Autoimmune Syndrome (Hirata disease)**, where antibodies bind insulin and release it inappropriately, rather than a tumor. **3. NEET-PG High-Yield Pearls:** * **Whipple’s Triad:** (1) Symptoms of hypoglycemia, (2) Low plasma glucose (<55 mg/dL), (3) Relief of symptoms after glucose administration. * **72-hour Fast:** The gold standard diagnostic test for insulinoma. * **Surfactant/Sulfonylurea Screening:** Always check for oral hypoglycemic agents, as they also increase both insulin and C-peptide (mimicking insulinoma). * **Localization:** Most insulinomas are small, solitary, and benign; they are localized using Endoscopic Ultrasound (EUS) or selective arterial calcium stimulation.

Question 88: Which one of the following conditions is associated with unconjugated hyperbilirubinemia?

A. Gilbert syndrome (Correct Answer)
B. Rotors syndrome
C. Crigler-Najjar syndrome
D. All of the above

Explanation: ### Explanation Hyperbilirubinemia is classified into **unconjugated (indirect)** and **conjugated (direct)** based on whether the defect occurs before or after the bilirubin is processed by the enzyme **UDP-glucuronosyltransferase (UGT1A1)** in the liver. **1. Why Gilbert Syndrome is Correct:** Gilbert syndrome is a common, benign autosomal recessive condition characterized by **reduced activity of UGT1A1** (typically ~30% of normal). This leads to impaired conjugation of bilirubin, resulting in isolated **unconjugated hyperbilirubinemia**. It typically manifests as mild jaundice triggered by stress, fasting, or illness. **2. Analysis of Other Options:** * **Crigler-Najjar Syndrome:** This condition also causes unconjugated hyperbilirubinemia. Type I involves a total absence of UGT1A1, while Type II involves a severe deficiency (<10%). **Note:** While Crigler-Najjar is technically correct, in many MCQ formats, if "All of the above" is provided but the specific source/context emphasizes the most common benign cause or if the question implies a specific clinical scenario, Gilbert is often the focus. However, strictly speaking, both A and C cause unconjugated hyperbilirubinemia. * **Rotor Syndrome:** This is a defect in the **hepatic storage/reuptake** of bilirubin. It results in **conjugated hyperbilirubinemia**. * **Dubin-Johnson Syndrome (Related):** Caused by a defect in the **MRP2 transporter**, leading to impaired excretion of conjugated bilirubin into the bile (also **conjugated hyperbilirubinemia**). **High-Yield Clinical Pearls for NEET-PG:** * **Unconjugated (Indirect):** Gilbert, Crigler-Najjar, Hemolysis. * **Conjugated (Direct):** Dubin-Johnson (Black liver), Rotor (No black liver). * **Phenobarbital:** Used to treat Crigler-Najjar Type II and Gilbert as it induces UGT1A1 activity. * **Diagnostic Test:** In Gilbert syndrome, jaundice increases with a **48-hour fast** (Caloric restriction test).

Question 89: False positive D-xylose test may be seen in which of the following conditions?

A. Blind loop syndrome
B. Ascites
C. Antibiotic therapy
D. All of the above (Correct Answer)

Explanation: **Explanation:** The **D-xylose absorption test** is used to differentiate between malabsorption caused by intestinal mucosal disease (e.g., Celiac disease) and malabsorption due to pancreatic insufficiency. D-xylose is a pentose sugar that is absorbed passively in the proximal small intestine and excreted unchanged in the urine. A "false positive" occurs when D-xylose levels in the urine are low despite normal intestinal mucosal function. **Why "All of the above" is correct:** 1. **Blind Loop Syndrome:** Small Intestinal Bacterial Overgrowth (SIBO) occurs here. The excess bacteria metabolize D-xylose before it can be absorbed by the intestinal mucosa, leading to low urinary excretion. 2. **Ascites:** D-xylose is a water-soluble sugar that can sequester into third-space fluids (like ascitic or edema fluid). This increases the volume of distribution and delays renal excretion, resulting in falsely low 5-hour urine levels. 3. **Antibiotic Therapy:** Certain antibiotics (e.g., neomycin, kanamycin) can interfere with the intestinal transport mechanisms or alter the flora in a way that reduces absorption, leading to a false positive result. **Other common causes of False Positives:** * **Renal Dysfunction:** The most common cause; impaired clearance leads to low urinary D-xylose despite normal absorption. * **Delayed Gastric Emptying:** Slows the delivery of the sugar to the absorptive site in the small intestine. * **Advanced Age:** GFR naturally declines with age, reducing excretion. **High-Yield Clinical Pearls for NEET-PG:** * **Normal Result:** >4g excretion in 5 hours (after a 25g oral dose) indicates intact mucosa. * **Pancreatic Insufficiency:** D-xylose test is **normal** because it does not require pancreatic enzymes for absorption. * **Celiac Disease:** D-xylose test is **abnormal** (low) due to mucosal atrophy. * **Patient Instruction:** Patients must be fasted, and adequate hydration is necessary to ensure sufficient urine flow.

Question 90: 5'-Nucleotidase activity is increased in which of the following conditions?

A. Bone diseases
B. Prostate cancer
C. Chronic renal failure
D. Cholestatic disorders (Correct Answer)

Explanation: **Explanation:** **5'-Nucleotidase (5'-NT)** is a glycoprotein enzyme found predominantly in the plasma membranes of hepatocytes, specifically localized to the canalicular and sinusoidal membranes. **Why Cholestatic Disorders is correct:** In **cholestatic disorders** (obstructive jaundice or intrahepatic cholestasis), bile salts exert a detergent effect on the hepatocyte membranes, causing the release and solubilization of 5'-NT into the circulation. Its clinical significance lies in its high specificity for **hepatobiliary disease**. While Alkaline Phosphatase (ALP) is also elevated in cholestasis, it is also found in bone. Therefore, 5'-NT is used to differentiate whether an elevated ALP is of hepatic or bony origin. **Why other options are incorrect:** * **A. Bone diseases:** Unlike ALP, 5'-NT levels remain **normal** in bone diseases (e.g., Rickets, Paget’s disease, or bone metastases). This makes it a superior marker for confirming liver pathology. * **B. Prostate cancer:** The specific marker for prostate cancer is **Prostate-Specific Antigen (PSA)** and historically, Acid Phosphatase (ACP). 5'-NT has no diagnostic value here. * **C. Chronic renal failure:** While many enzymes can be deranged in uremia, 5'-NT is not a marker for renal function or damage. **High-Yield Clinical Pearls for NEET-PG:** * **ALP vs. 5'-NT:** If both are elevated → Hepatobiliary origin. If ALP is elevated but 5'-NT is normal → Bone origin. * **Gamma-Glutamyl Transferase (GGT):** Similar to 5'-NT, GGT is also elevated in cholestasis and normal in bone disease. However, GGT is also induced by **alcohol** and drugs (enzyme induction), whereas 5'-NT is not. * **Pregnancy:** 5'-NT levels remain normal during pregnancy, whereas ALP levels increase due to the placental isoenzyme.

Practice by Chapter

Liver Function Tests

Practice Questions

Kidney Function Tests

Practice Questions

Cardiac Markers and Enzymes

Practice Questions

Pancreatic Function Tests

Practice Questions

Glucose Tolerance Tests

Practice Questions

Lipid Profile and Cardiovascular Risk

Practice Questions

Tumor Markers

Practice Questions

Hormonal Assays and Interpretation

Practice Questions

Electrolytes and Acid-Base Balance Tests

Practice Questions

Cerebrospinal Fluid Analysis

Practice Questions

Point-of-Care Testing

Practice Questions

Quality Control in Clinical Biochemistry

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free